Reduction of increased serum neutrophil chemotactic activity following effective hyposensitization in house dust mite allergy
- 1 May 1989
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 19 (3) , 327-334
- https://doi.org/10.1111/j.1365-2222.1989.tb02391.x
Abstract
Changes in the level of serum neutrophil chemotactic activity (S-NCA) were investigated in 20 subjects with allergic rhinitis, with or without asthma, undergoing clinically effective hyposensitization to house dust mite with Pharmalgen Dermatophagoides pteronyssinus. Two control groups were studied: 28 subjects with allergic rhinitis, with or without asthma, receiving placebo injections for 1 yr in a double-blind controlled trial with Pharmalgen D. pteronyssinus (from whom the actively treated group in this study were recruited), and eight non-atopic asymptomatic controls. S-NCA and serum IgE specific to D. pteronyssinus were measured in the subjects before, during (3-6 months) and 12 months after treatment, and once in the non-atopic controls. The mean S-NCA was significantly higher (0.01 > P > 0.001) in subjects before treatment (mean .+-. s.e. = 63.8 .+-. 3.6 arbitary units of migration (AUM) compared with the non-atopic controls (48.5 .+-. 3.7 AUM), but had fallen to normal levels after 6 months (46.8 .+-. 4.0 AUM) and 12 months treatment (45.2 .+-. 3.8 AUM). The levels of S-NCA in the placebo treated group were significantly higher than normal at the start of treatment (69.2 .+-. 4.1) and remained raised throughout the 12 months treatment. In the actively treated group, the level of S-NCA had fallen in 18 out of 19 subjects after 12 months immunotherapy, and was unaltered in one. Mean levels of D. pteronyssinus IgE rose during the first 6 months and declined to initial levels by the end of the treatment. We suggest that the elevated S-NCA may play a role in the maintenance of the allergic state through the induction of the late-phase reaction; that the abnormal S-NCA production is reduced by effective hyposensitization, and that measurement of S-NCA may be useful to monitor hyposensitization therapy. Complete characterization of S-NCA and the mechanisms of its control remain to be investigated.This publication has 26 references indexed in Scilit:
- Circulating Histamine and Neutrophil Chemotactic Activity During Allergen-Induced Asthma: The Effect of Inhaled Antihistamines and Anti-Allergic CompoundsClinical Science, 1985
- Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patientsJournal of Allergy and Clinical Immunology, 1984
- Immunologic studies in allergen-induced late-phase asthmatic reactionsJournal of Allergy and Clinical Immunology, 1984
- Induction of nasal late-phase reactions by insufflation of ragweed-pollen extractJournal of Allergy and Clinical Immunology, 1984
- Neutrophil chemotactic factor of anaphylaxisJournal of Allergy and Clinical Immunology, 1982
- Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliberJournal of Allergy and Clinical Immunology, 1982
- CONTROLLED TRIAL OF HYPOSENSITISATION TO DERMATOPHAGOIDES PTERONYSSINUS IN CHILDREN WITH ASTHMAThe Lancet, 1978
- Release of Neutrophil Chemotactic Activity during Immediate Hypersensitivity Reactions in HumansAnnals of Internal Medicine, 1977
- The selective eosinophil chemotactic activity of histamine.The Journal of Experimental Medicine, 1975
- Histologic studies of human skin test responses to ragweed, compound , and histamineJournal of Allergy and Clinical Immunology, 1973